Camacho AJF

Language: Spanish
References: 21
Page: 321-326
PDF size: 91.54 Kb.

ABSTRACT

Jean-Martin Charcot (1825-1893) was a French physician whose professional life is divided into two phases: the first dedicated to neurology, and the second dedicated to the psychiatry area. Charcot is considered the father of modern neurology. In the Hospice de la Salpêtrière he began his research on neurological diseases, founded a laboratory of pathology (including microscopy and photography), and gave hospital classes based on pathological anatomy related to clinical manifestations based in the field of neurology. His research led to the description and study of different neurological diseases, such as multiple sclerosis, lateral amyotrophic sclerosis, hereditary motor and sensory neuropathy, motor ataxia, Parkinson's disease, Gilles de la Tourette syndrome, epilepsy, visual aphasia and agnosia, to name a few. Some signs and diseases took their name as an eponym, and some are still mentioned in the current medicine, while others are left in oblivion.

REFERENCES

1. Barquin CM. Historia de la medicina, su problemática actual. 5.a ed. México: Ed. Librería de Medicina; 1980. p. 300-1.

2. Jay V. The legacy of Jean-Martin Charcot. Arch Pathol Lab Med. 2000;124:10-1.

3. Miller H. Three great neurologist. Proc R Soc Med. 1967;60:399-405.

4. Tan SY, Shigaki D. Jean-Martin Charcot (1825-1893): pathologist who shaped modern neurology. Singapore Med J. 2007;48:383-4.

5. Teive HAG, Puppi MR, Reis BE. Little-known contributions of J-M Charcot. Clinics. 2007;62:211-4.

6. Lennox TA. Jan-Martin Charcot, 1825-1893. An appreciation. Brit J Vener Dis. 1967;43:77-80.

7. Goetz CG. Jean-Martin Charcot (1825-1893). J Neurol. 2005;252: 374-5.

8. Parry JW. «Caesar of the Salpêtrière» J.-M. Charcot’s impact on psychological medicine in the 1880s. Bul Royal Coll Psychiatrists. 1987;11:150-3.

9. Kimura Y, Takada T, Kawarada Y, et al. Definitions, pathophysiology, and epidemiology of acute colangitis and cholecystitis: Tokyo guidelines. J Hepatobiliary Pancreat Surg. 2007;14:15-26.

10. Gjessing HGA. The value of eye symptoms in the diagnosis of general diseases. Brit Med J. 1934;1(3821):567-71.

11. Muira F, Takada T, Kawarada Y, et al. Flowcharts for the diagnosis and treatment of acute cholangitis and cholecystitis: Tokyo Guidelines. J Hepatobiliary Pancreat Surg. 2007;14:27-34.

12. Wijesekera LC, Nigel LP. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:3.

13. Banchs I, Casasnovas C, Alberti A, et al. Diagnosis of Charcot-Marie- Tooth disease. J Biomed Biotech. 2009;2009:985415.

14. Campbell DJ, Doyle JO. Tabetic Charcot’s spine. Brit Med J. 1954; 1(4869):1018-20.

15. Contrepois A. The clinician, germs and infectious diseases: The example of Charles Bouchard in Paris. Med History. 2002;46:197-220.

16. Bresch D. Beyond Wernicke’s: A lexicon of eponyms in psychiatry. J Neuropsychiatry Clin Neurosci. 2002;14(2):155-60.

17. Bassetti CL, Bischof M, Valko P. Dreaming: a neurological view. Schweiz Arch Neurol Psychiatr. 2005;156:399-414.

18. Victor M, Ropper AH. Adams and Victor’s principles of neurology. 7.a ed. Nueva York: McGraw-Hill; 2001. p. 673.

19. Jost WH. A tribute to Wilhelm H. Erb. J Neurol. 2006;253(Suppl 1):I/1-/12.

20. Codell CK. Germ theory, hysteria, and Freud’s early work in psychopathology. Med Hist. 1980;24:259-74.

21. El-Hashimi W. Charcot-Leyden crystals. Amer J Path. 1971;65: 311-24.